Expansion opportunity Recent launch of expanded truncal compression garment line indicates product portfolio growth and a potential cross-sell to existing lymphedema customers and clinics requiring broader garment options.

Leadership addition Appointment of a new Chief Operating Officer suggests potential strategic shifts and renewed execution capabilities, presenting an opening to align sales pitches with any new operations or distribution initiatives.

Clinical alignment Focused medical device offerings for lymphedema, CVI, PAD, and arterial conditions align with high-need vascular and wound care markets, signaling opportunities with vascular clinics, physical therapy centers, and home health providers.

Regulatory maturity History of FDA clearances and regulatory experience supports partnership with hospital systems and durable medical equipment (DME) distributors seeking compliant, ready-to-market compression therapies.

SMB scale strengths Small-to-mid enterprise footprint with a revenue range of 1—10 million and a focused product line presents scalable, direct-to-clinic and e-commerce sales opportunities, including potential channel partnerships with similar-sized distributors.